Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Stanford MedX 2015

991 views

Published on

Presentation for abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” at Stanford MedX 2015

Published in: Health & Medicine
  • Login to see the comments

  • Be the first to like this

Stanford MedX 2015

  1. 1. USING DISPARATE SOURCES OF DATA TO PERSONALIZE DIGITAL BEHAVIOR CHANGE INTERVENTIONS Amos Adler M.Sc. MEMOTEXT® Personalized Adherence Solutions @amosadler @MEMOTEXT HELLO MedX!
  2. 2. EVERYONE IS DIFFERENT. PEOPLE CHANGE.
  3. 3. 3 Biometrics • Wearables • EMR Claims & Refill Patient Self-Report • Understanding • Behavior • QOL Building validated, evidence-based, personalized adherence communications. ACTION MY DAMN DATA! SUBJECTIVE OBJECTIVE EVIDENCE BASED DESIGN PERSONALIZATION PATIENT SELECTED MEDIA
  4. 4. SO YOU WANT TO DO TEXT REMINDERS? TAKE YOUR PILLS
  5. 5. FROM REMINDERS TO RELEVANCE
  6. 6. BREATHE
  7. 7. EVIDENCE-BASED DESIGN » YOUR DATA » RELEVANCE = ENGAGEMENT » BEHAVIOR CHANGE
  8. 8. TO CREATE BEHAVIOR CHANGE @MEMOTEXT #adherenceMethodology WHAT DATA DO I NEED?
  9. 9. EVIDENCE-BASED DESIGN » YOUR DATA » RELEVANCE = ENGAGEMENT » BEHAVIOR CHANGE
  10. 10. SUBJECTIVE HEALTH DATA Depression Self-Efficacy Literacy/ Knowledge Stage of Change Lifestyle Anxiety Expectation QOL
  11. 11. 1. RX History 2. Comorbidities 3. Delays to refill 4. Real-time Activity 5. Real-time Blood Glucose OBJECTIVE HEALTH DATA
  12. 12. EVIDENCE-BASED DESIGN » YOUR DATA » RELEVANCE = ENGAGEMENT » BEHAVIOR CHANGE
  13. 13. Support WEIGHTED DISTRIBUTION OF CONTENT Mindfulness Motivation Condition Literacy Medication Literacy Device information Nutrition Escalation Triggers Risk Identification Lifestyle
  14. 14. NEW RULES OF ENGAGEMENT: CREATE PROGRAMS THAT DON’T SUCK Can we please move from this…
  15. 15. ENGAGE FIRST. HEALTH SECOND. diSRuPT? To this…
  16. 16. EVIDENCE-BASED DESIGN » DATA = RELEVANCE » RELEVANCE=ENGAGEMENT » BEHAVIOR CHANGE
  17. 17. : MEMOTEXT® EFFECT › RANDOMIZED CLINICAL TRIAL JOHNS HOPKINS UNIVERSITY RECRUITMENT: JHU Research / MS Healthvault CONDITION: Glaucoma (Travatan/Xalatan) Michael V. Boland MD PhD. – Wilmer Eye Clinic Johns Hopkins Univ. 3MONTHS ›MonitorAdherence for3months<75% RANDOMIZE ›PoorAdherence ›GoodAdherence 6MONTHS ›MEMOTEXT group ›Control group INITIAL (%) FINAL (%) 49 % 50% 51% 67% CONTROL INTERVENTION
  18. 18. REAL-WORLD DATA PHARMACY 18-MONTH TYPE 2 DIABETES METFORMIN DEPRESSION SELF-EFFICACY UNDERSTANDING 18 MONTH INTERVENTION REFILL AVG 2.6 DAYS EARLIER
  19. 19. REAL-WORLD DATA HEALTH PLAN 10-MONTH DATA – HYPERTENSION + CHOLESTEROL NEW STARTS INTENT TO ADHERE, CONDITION LITERACY RX HISTORY CHOICE ON CONTENT PERSISTENCE BY 37.3 % ONE-AND- DONE POPULATION 22.5 - 13.5% COMPLIANCE RATE 35.6% to 49.5% v v
  20. 20. LISTEN » GUIDE » MOTIVATE
  21. 21. Evidence Based • Personalized • Validated • Integrated • Secure Thank you! @amosadler

×